These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34281467)

  • 1. Metformin for diabetes prevention: update of the evidence base.
    Hostalek U; Campbell I
    Curr Med Res Opin; 2021 Oct; 37(10):1705-1717. PubMed ID: 34281467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
    Aroda VR; Knowler WC; Crandall JP; Perreault L; Edelstein SL; Jeffries SL; Molitch ME; Pi-Sunyer X; Darwin C; Heckman-Stoddard BM; Temprosa M; Kahn SE; Nathan DM;
    Diabetologia; 2017 Sep; 60(9):1601-1611. PubMed ID: 28770322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):866-75. PubMed ID: 26377054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
    Perreault L; Pan Q; Mather KJ; Watson KE; Hamman RF; Kahn SE;
    Lancet; 2012 Jun; 379(9833):2243-51. PubMed ID: 22683134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of metformin for diabetes prevention.
    Slama G
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S104-11. PubMed ID: 14502107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.
    Goldberg RB; Aroda VR; Bluemke DA; Barrett-Connor E; Budoff M; Crandall JP; Dabelea D; Horton ES; Mather KJ; Orchard TJ; Schade D; Watson K; Temprosa M;
    Circulation; 2017 Jul; 136(1):52-64. PubMed ID: 28476766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2012 Apr; 35(4):723-30. PubMed ID: 22442395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of lifestyle and metformin interventions in DPP on bone density.
    Schwartz AV; Pan Q; Aroda VR; Crandall JP; Kriska A; Piromalli C; Wallia A; Temprosa M; Florez H;
    Osteoporos Int; 2021 Nov; 32(11):2279-2287. PubMed ID: 34086101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
    Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study.
    Goldberg RB; Orchard TJ; Crandall JP; Boyko EJ; Budoff M; Dabelea D; Gadde KM; Knowler WC; Lee CG; Nathan DM; Watson K; Temprosa M;
    Circulation; 2022 May; 145(22):1632-1641. PubMed ID: 35603600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
    Palmer AJ; Tucker DM
    Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.
    Ratner RE; Christophi CA; Metzger BE; Dabelea D; Bennett PH; Pi-Sunyer X; Fowler S; Kahn SE;
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4774-9. PubMed ID: 18826999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
    Palmer AJ; Roze S; Valentine WJ; Spinas GA; Shaw JE; Zimmet PZ
    Clin Ther; 2004 Feb; 26(2):304-21. PubMed ID: 15038953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM; Schlessinger L; Kahn R
    Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2019 Apr; 42(4):601-608. PubMed ID: 30877090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study.
    Herman WH
    Clin Diabetes Endocrinol; 2015; 1():9. PubMed ID: 28702228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.
    Goldberg RB; Temprosa M; Haffner S; Orchard TJ; Ratner RE; Fowler SE; Mather K; Marcovina S; Saudek C; Matulik MJ; Price D;
    Diabetes Care; 2009 Apr; 32(4):726-32. PubMed ID: 19171717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program.
    Perreault L; Kahn SE; Christophi CA; Knowler WC; Hamman RF;
    Diabetes Care; 2009 Sep; 32(9):1583-8. PubMed ID: 19587364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.